BCDA
BioCardia, Inc.
Latest Form 4:Purchase$5KbyAltman Peter (President and CEO) · filed Aug 18, 2026
BioCardia, Inc. (BCDA) has 31 SEC Form 4 filings (44 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 18, 2026.
The most active filer is President and CEO Altman Peter with 27 filings. Insiders have net bought $157K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Peter A. Altman
- Employees:17
- HQ:Sunnyvale, CA, US
- IPO:1996-11-13
Insider Buying
$1.1M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$17.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| President and CEO | Purchase | 5,400 | $5K | Aug 18 | SEC ↗ | |
| President and CEO | Purchase | 1,900 | $2K | Aug 13 | SEC ↗ | |
| President and CEO | Purchase | 5,000 | $4K | Jul 30 | SEC ↗ | |
| President and CEO | Purchase | 500 | $415 | Jul 20 | SEC ↗ | |
| President and CEO | Purchase | 2,800 | $2K | Jul 15 | SEC ↗ | |
| President and CEO | Purchase | 1,500 | $1K | Jul 15 | SEC ↗ | |
| President and CEO | Purchase | 10,900 | $11K | Jul 10 | SEC ↗ | |
| President and CEO | Purchase | 1,000 | $900 | Jul 10 | SEC ↗ | |
| President and CEO | Purchase | 1,000 | $940 | Jul 10 | SEC ↗ | |
STERTZER SIMON HFirst in 9 months | Director | Purchase | 70,200 | $65K | Jun 24 | SEC ↗ |
STERTZER SIMON HFirst in 9 months | Director | Purchase | 39,000 | $39K | Jun 24 | SEC ↗ |
| President and CEO | Purchase | 1,500 | $1K | Jun 22 | SEC ↗ | |
| President and CEO | Purchase | 800 | $768 | Jun 22 | SEC ↗ | |
| President and CEO | Purchase | 5,000 | $4K | Jun 9 | SEC ↗ | |
| President and CEO | Purchase | 200 | $190 | May 21 | SEC ↗ | |
| President and CEO | Purchase | 1,500 | $1K | May 21 | SEC ↗ | |
| President and CEO | Purchase | 5,700 | $5K | May 19 | SEC ↗ | |
| President and CEO | Purchase | 5,100 | $5K | May 15 | SEC ↗ | |
| President and CEO | Purchase | 5,000 | $6K | Apr 29 | SEC ↗ | |
| President and CEO | Purchase | 600 | $738 | Apr 22 | SEC ↗ | |
| President and CEO | Purchase | 400 | $492 | Apr 22 | SEC ↗ | |
| President and CEO | Purchase | 600 | $744 | Mar 26 | SEC ↗ | |
| President and CEO | Purchase | 300 | $366 | Mar 26 | SEC ↗ | |
| President and CEO | Purchase | 5,000 | $6K | Feb 4 | SEC ↗ | |
| President and CEO | Purchase | 600 | $792 | Jan 21 | SEC ↗ | |
| President and CEO | Purchase | 300 | $402 | Jan 21 | SEC ↗ | |
| President and CEO | Purchase | 200 | $274 | Dec 17 | SEC ↗ | |
| President and CEO | Purchase | 900 | $1K | Dec 17 | SEC ↗ | |
Altman PeterFirst filing | President and CEO | Purchase | 48,000 | $60K | Sep 23 | SEC ↗ |
Blank Andrew ScottFirst filing | Director | Purchase | 288,000 | $360K | Sep 23 | SEC ↗ |
STERTZER SIMON HFirst filing | Director | Purchase | 398,400 | $498K | Sep 23 | SEC ↗ |
Related companies
BioCardia, Inc. is in the Healthcare sector.